Pulmonary Embolism Syncope-Anemia-Renal Dysfunction (PE-SARD) Score
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–0
- Intermediate Risk1–2.5
- High Risk2.5–5
The Pulmonary Embolism Syncope-Anemia-Renal Dysfunction (PE-SARD) Score calculates rapid bedside triage, risk stratification, and urgent clinical decision-making. Key inputs include syncope. Scores guide determining acute hospital admission, emergency department discharge safety, or intensive care transfer. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Estimates risk of early major bleeding in patients with acute pulmonary embolism (PE). This validated risk assessment tool helps clinicians identify PE patients at higher risk for bleeding complications within 30 days of diagnosis, assisting in treatment decisions and management planning.
Clinical Indication
The Pulmonary Embolism Syncope-Anemia-Renal Dysfunction (PE-SARD) Score is indicated for bedside clinical practice to support Estimates risk of early major bleeding in patients with acute pulmonary embolism (PE). This validated risk assessment tool helps clinicians identify PE patients at higher risk for bleeding complications within 30 days of diagnosis, assisting in treatment decisions and management planning.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult and pediatric patients presenting with acute undifferentiated clinical complaints, trauma, or unstable vital signs. Clinical application is indicated across Emergency triage, acute resuscitation bays, observation units, and emergency trauma centers.
Limitations & Contraindications
Score calculations must never delay immediate life-saving airway stabilization, vascular access, or emergent surgical consult.
Clinical Pearls & Action Plan
Adherence to core ABCDE resuscitation principles and bedside clinical gestalt must take absolute precedence over numerical decision tools.
PE-SARD Score = 1.5×(if syncope) + 2.5×(if anemia Hgb <12 g/dL) + 1×(if renal dysfunction GFR <60 mL/min)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| syncope | string | Yes | History of syncope at presentation or shortly before PE diagnosis |
| anemia | string | Yes | Anemia defined as hemoglobin level less than 12 g/dL |
| renal_dysfunction | string | Yes | Renal dysfunction defined as glomerular filtration rate (GFR) less than 60 mL/min/1.73m² |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0 | Low Risk | Low bleeding risk |
| 1–2.5 | Intermediate Risk | Intermediate bleeding risk |
| 2.5–5 | High Risk | High bleeding risk |
Evidence-Based References (EBM)
- Barrios D, Rosa-Salazar V, Morillo R, Nieto R, Fernández-Golfín C, Zamorano JL, et al. An Original Risk Score to Predict Early Major Bleeding in Acute Pulmonary Embolism: The Syncope, Anemia, Renal Dysfunction (PE-SARD) Bleeding Score. Chest. 2021 Sep;160(3):992-1000. doi: 10.1016/j.chest.2021.04.063.DOI: 10.1016/j.chest.2021.04.063
- Lobo JL, Zorrilla V, Aizpuru F, Grau E, Jiménez D, Prandoni P, et al. External validation of the PE-SARD risk score for predicting early bleeding in acute pulmonary embolism in the RIETE Registry. Thromb Res. 2024 Mar;235:176-181. doi: 10.1016/j.thromres.2024.01.016.DOI: 10.1016/j.thromres.2024.01.016
- Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, et al. External validation of the Pulmonary Embolism-Syncope, Anemia, and Renal Dysfunction bleeding score for early major bleeding in patients with acute pulmonary embolism: from the COMMAND VTE Registry-2. J Thromb Thrombolysis. 2024 Aug;58(2):357-365. doi: 10.1007/s11239-024-02988-4.DOI: 10.1007/s11239-024-02988-4